Co-Authors
This is a "connection" page, showing publications co-authored by Fabrizio Conti and Ennio Favalli.
Connection Strength
0.240
-
Comments on "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study". J Am Acad Dermatol. 2018 12; 79(6):e119-e120.
Score: 0.195
-
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. Autoimmun Rev. 2017 Sep; 16(9):911-924.
Score: 0.045